Taleen Barsoumian is Vice President of Client Development at Forge Biologics. Previously, she was the US Director of Sales & Business Development for Cell & Gene at Barkey Corporation (subsidiary of Barkey GmbH & Co. KG), a medical device leader specializing in the science of precise dry temperature thawing used in product development, clinical trials and cGMP compliant manufacturing of cell and gene therapies. She was directly responsible for leading and executing many noteworthy partnerships with FDA approved CAR T-Cell therapy teams as well as closely collaborating with study sponsors in their ongoing Phase I, II and III clinical research trials. Prior to joining Barkey, she was the BioScience Western Regional Sales Manager for North America at Greiner Bio-One, internationally known for its Life Science products used in the cultivation and analysis of cell and tissue cultures as well as three-dimensional (3D) cell-based assays with imaging. She led a team with high profile accounts in academia, biotech, pharma, government and diagnostics. Her initial introduction into the therapeutics industry was with Novartis Pharmaceuticals, where she spent over seven years as a Senior Cardiovascular Sales Consultant and was responsible for the successful launch of seven FDA approved products into the Anti-Hypertensive market. Ms. Barsoumian earned her B.S from the Keck School of Medicine at the University of Southern California (USC) in Health Promotion & Disease Prevention Studies/Epidemiology and also holds a Pharmacy Technician License from the California State Board of Pharmacy.